← FDA Drug Approvals (Drugs@FDA)
TRI-LEGEST 21
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2007-10-26
Drug application
- FDA Application #
ANDA076405- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRI-LEGEST 21
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL-21
- Marketing status
- Discontinued
- Sponsor
- BARR
- First approval
- 2007-10-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown